Drug Sponsors Invited To Trial Pre-Submission Meetings With South African Agency
The South African Health Products Regulatory Authority is planning to introduce meetings with drug sponsors that can help identify and resolve potential shortcomings in marketing applications before they are submitted for evaluation.
You may also be interested in...
The International Council for Harmonisation has delivered the first of a two-part project to modernize the international good clinical practice framework by finalizing changes to its primary efficacy guideline.
EU reviewers have recommended five new medicines and a pneumococcal vaccine for EU-wide approval. New uses of several approved medicines have also drawn the thumbs up, while the sponsor of a cancer drug has withdrawn its product from the review process.
Following Orphazyme’s disappointment in the US regarding its investigational drug for an ultrarare disease, the company has said it will need more time to address outstanding issues raised by EU reviewers about the same medicine.